{"name":"OM Pharma SA","slug":"om-pharma-sa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Broncho-Vaxom","genericName":"Broncho-Vaxom","slug":"broncho-vaxom","indication":"Recurrent respiratory tract infections (sinusitis, otitis media, bronchitis, pneumonia)","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"OM-85","genericName":"OM-85","slug":"om-85","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Broncho-Vaxom","genericName":"Broncho-Vaxom","slug":"broncho-vaxom","phase":"phase_3","mechanism":"Broncho-Vaxom is an oral immunostimulant that enhances innate and adaptive immune responses to prevent recurrent respiratory tract infections.","indications":["Recurrent respiratory tract infections (sinusitis, otitis media, bronchitis, pneumonia)","Chronic obstructive pulmonary disease (COPD) with recurrent exacerbations"],"catalyst":""},{"name":"OM-85","genericName":"OM-85","slug":"om-85","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQOVNCZXExTzlIR0dYVzZEXzM1Z0RUSnc2NnhIc1RHQXBZX0FsTjNfX3prdkNsdnpxRUNTem1YTFpndG9Pb2hNcFRoUlJjM19EeW1tVjdDeE5rZHZwVnJvVmFCMXdDWnRlYTJ0NGs4QVpxcHFkYUt3SnZrREhrSG1PWXgtN1I3cTJLRUlpQWhjbDZhUjJGakJIbW5xVnA5T3RsVml4Z1I4UTAxZHpwYTZGRTBzX3l0dUhoTTJ3WTF3?oc=5","date":"2026-03-26","type":"pipeline","source":"Investing.com","summary":"BMO upgrades ICON stock rating on pharma backdrop improvement - Investing.com","headline":"BMO upgrades ICON stock rating on pharma backdrop improvement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPWW1VSTNGbWt3cnlkX3duUmlpdWg1NUk4SUtLVnVfeVczOGtMYmg5RFdWdW1OV1BpT1BGd1c5RF9wdFd6RGw5SEh6aFBYd240VHRhRnpvdEd3OFNUNXB6TzJyVmhtNXFab0VPQUNIMnBVY0dSVlhBbnBwaEVCY1NMRk1xdF9YNkdNVFlWdGhTdGdiXzBoS1QzRlZ6bHVELW5ZS0d6Tm5IWmJwekVQZ2gzcHNmNHRJQllvYktXNw?oc=5","date":"2026-03-25","type":"earnings","source":"Investing.com South Africa","summary":"Aptamer Group reports 27% revenue growth on pharma contracts By Investing.com - Investing.com South Africa","headline":"Aptamer Group reports 27% revenue growth on pharma contracts By Investing.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeUNRUGM2U1JkTTFraUJ1WThhOUZZb1ZiVzg1OWtGNzgyMHRhcWU1YWZLLWZ6Zzk1RkhqQk5mQ2Y4eUM1SkZadldveUlkZTc0bWdMZGFZQnM2Y1RLbDBNMGN0ck5aWjFwMGFsNzluYVNnTkR5dVg5TC1JZDcybnJSVHRVRHhENmJNaXJsdlpCSU1EYTZrVFFoTEVYZDBJcWd4RUhsSXhCdG92MU5hWWZJSkhhWlZyVFJxQnF3ZEQ4WWg?oc=5","date":"2026-02-27","type":"pipeline","source":"Investing.com South Africa","summary":"Raymond James cuts GoodRx stock price target on pharma headwinds By Investing.com - Investing.com South Africa","headline":"Raymond James cuts GoodRx stock price target on pharma headwinds By Investing.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNQXd1RVFfdlZLSWlSSE14eDZZbjZ5NHNfQVVPSFF1ZHZJajZVZXBGM1dUS2pCbFJpeEpWa19kQlhfQm5UclJSVmxvd0xDT3R6ZXFqWGU2VlQxTzVpYzluTVk1NDJLM2FzMnh6NnlaWVYzOVRsblEzZ0Z0SEtFZF9iYWpWUFlUMUlrRE9ISFhNd1c4cy1CeXRsY3g2LTVPRGI0Y21PeWpBSm53ejM4aGxzSkNuQW5TSTgzYnRSWVIxUlVwdExoWTRF?oc=5","date":"2025-12-29","type":"pipeline","source":"seekingalpha.com","summary":"My Market Outlook For 2026: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares - seekingalpha.com","headline":"My Market Outlook For 2026: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOUXAzMzVHTzRpdUJWQXZaaDZ0dHpBVTNYeXBaS0NXUXhWTERlMUhaaWttbE5ZcHAtZFFxV1J5ZVFUSEx2V1VFN1I0TWxvcE91cUt2VUQxWXBYWnNtUURzUFlSSHdXbUFOWTJPNjQ1Q3pfaGZjWDlfb1pWSEtDWXhwSExCczBkQ25aS2dKd2UwNjVXSFpvYXdQVmhta2lQb0U2bTFvZXhDYkJtdnVyTENiTlpIQmdCVG8?oc=5","date":"2025-12-29","type":"pipeline","source":"Analyst Group","summary":"Comment on Pharma Equity Group’s Strategic Update and Adjustment of Expectations - Analyst Group","headline":"Comment on Pharma Equity Group’s Strategic Update and Adjustment of Expectations","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-02","type":"pipeline","source":"simplywall.st","summary":"Pharma Mar, S.A. (BME:PHM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st","headline":"Pharma Mar, S.A. (BME:PHM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPcGt5Z2h1Z0FhN09DZEJBVWtlWVMzMFVreXJGa2VCbWt4Ykw4MXBrM2FETEdCbk00cEVvOWtQQ0VEc3JpWEZwZXRRMl94NEVUVXJWXzZUaTBRcEVVN3NwWWFTVEVacm5JZll6UmdtR0h0X20tMG5RQ3g2Vi1GcWE2X1RubkgtT2Z1b05BaDhhWTJoUHVPdDEtaGhlY0ZLM1lfOHRtNA?oc=5","date":"2025-09-26","type":"pipeline","source":"Euronews.com","summary":"Pharma tariffs: The EU's confident it can dodge US measures - Euronews.com","headline":"Pharma tariffs: The EU's confident it can dodge US measures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPMm5YTktSTG5Kaks3UTdwSzh6bTlUUWtvR2gzdmdKa2FDd1BjMTFJUGxkWXFVWms1TDE5Umo5ZWQzYzhlTGt1UFBiaUxtUExlTzlXQXl5Q09jbkUwNW1UcWItVjF4NV9QTWRSekxtU2tWeWV0WmxvU2ZudHR0MW5ULVFuUmkwdmMxV2NDV3B5VmRmdE5DNUhNT3lsakRIZFpPTEFuTnVpeHhtaVpXLWZWUUFJYzNjQ3RRN2pLLVdmNWRjM1lEN2pXVnFaWW1TbnYycHoyc3dTRdIB3AFBVV95cUxPV1RiNXlrM1NXY3E3cG0ydGNWcmotVHJpdmI3a1ZoN1gyWVJPZDlubVhnNzRNTVg5SGNiMm1xTlh4R3NSb1R1ZnNvdzhSNkN1OFR0dXdCb2ExZTBQOU0wcHdnQTJOZzRtQUZkNzFQckVaRTM5M2l3Z0xlajVrMjdXY2RDYWQ5ZnhoOGZZdDhXSlJ0ZmJ3aGxoblgwTWxGQ0gwc0pza3NERG9rUTMtRngtTXp6MU8tVk5TbTFLdEVDZlVKeV9reThRdUo0Qm81S3cxM1ZIZTFySGlNVXQ1?oc=5","date":"2025-09-26","type":"pipeline","source":"hindustantimes.com","summary":"How Trump's 100% tariff on pharma imports could impact India. Explained | India News - hindustantimes.com","headline":"How Trump's 100% tariff on pharma imports could impact India. Explained | India News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOcVlwRTBIZEJkS18tYUFJYWZIQko0dVhwUHVmNzJ1Ui1YYVdza1FYbXl1T3VoNVQ1dzlRWjFDQ2dJTFVxeHlmeUpfaW1BVXFmY1VLaWpvcDBzMkdaS3JQQjIxVGlmd0FFV2U4Y0paSUNSNTlkMmJ5a3RZMHE2NUhkaE82czdiUdIBiwFBVV95cUxNV0QzelljRWZKa0ZpX2R6ZnJMSDdSQ0hNbmhPUWRhdzRWME9Tdnh6X05JR2tlZ05wdUc3WXlqRS1OTFFhaXQ1UWZnYl8xT0xTa0pNMUF0Vnk0WnlVb3JJR3I3SVoyRkJEUVZTQnJZS3RmRU8tWFk2LU1oVHptV0lJR0VZblMycWx2UTc4?oc=5","date":"2025-07-08","type":"pipeline","source":"CNBC","summary":"Trump threatens to impose up to 200% tariff on pharmaceuticals 'very soon' - CNBC","headline":"Trump threatens to impose up to 200% tariff on pharmaceuticals 'very soon'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOMTRxdWQ1VURpZEFDYzFpWFVZZHZQbVFpRzkwOU5EN3Bpdk5MelhWTnBvTTBVQVpHRGlhMExtM3VoeUJXMUpndWVabUFHWlVKOGZ1RFhlWExPNGNiQzhnRzdzZUhqRjhsbjVwRzhjeGlPYnUyblp2ZEJROVgwYWo2WUhWVDVUdWdiTmlYek1zekJGdWUxTkM0eGVPLWk0TGNNa0xrNVFseGUxb0dCY190SmFPOEFlY0NzZ0E?oc=5","date":"2025-06-30","type":"pipeline","source":"Pharmaceutical Technology","summary":"US trade tariffs and the potential impact on pharma supply chains - Pharmaceutical Technology","headline":"US trade tariffs and the potential impact on pharma supply chains","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1wYWlyaTJNNjB3UGxyRkxkMmtNUjAwS2NFMFR0UU5RejFxS0ViSzROQS1RWVV1d01aRDk2NFkydUNpZFhHQTJWaDJwVjNjUnFmdmc4aFd3aXBicFRvWjFaV2d3RjJmTHNVM3VaanZLNF9CZ0ZWSnA4?oc=5","date":"2023-06-01","type":"pipeline","source":"Global Biotechnology Company","summary":"Global Biotechnology Company - Global Biotechnology Company","headline":"Global Biotechnology Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQRm5VQWN0cXlNc1dPQklnelcwS0h0ekxaTlRBbjQ4SWpXemwwbGVNSVZlYkdSUGhvVUk4VmhBSjJNWlNQNklBSUtqelJjLUZYUjl3VVVBM1NaTlgwMGt5bUJKRFJqclFTcllHaF9YcVRTanNXNkwtVXZkV0pXdkltZjVXZTlmRGRCMU4za3JlajMtZ3V6WWZYNkFmbk4zQ01aS3lYWnF1Z0FINGZ3OTJrYk1PZUxoX3dWZUxLbGwxNGlQbTl6XzZQVGN2TWVjdW9QZi0xMG95TzlvQVpJM2c?oc=5","date":"2022-02-01","type":"pipeline","source":"PR Newswire","summary":"CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma - PR Newswire","headline":"CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}